Bioventus (BVS) Net Income (2020 - 2026)

Bioventus (BVS) has reported Net Income for 7 consecutive years, with $36.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income rose 290.48% year-over-year to $36.2 million; the trailing twelve-month figure through Jun 2026 stood at $61.5 million (up 12370.46% YoY), and the FY2025 full-year result was $27.3 million, up 157.97% from the prior year.
• Net Income improved to $36.2 million in Q2 2026 per BVS's latest filing, from $3.9 million in the prior quarter.
• Across five years, Net Income topped out at $36.2 million in Q2 2026 and bottomed at -$174.4 million in Q2 2023.
• Historically, Net Income has averaged -$21.6 million across 5 years, with a median of -$6.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Net Income plunged 179392.0% in 2022, then soared 2971.97% in 2025.
• Over 5 years, Net Income stood at -$44.9 million in 2022, then soared by 82.94% to -$7.7 million in 2023, then soared by 92.12% to -$603000.0 in 2024, then jumped by 2971.97% to $17.3 million in 2025, then surged by 109.06% to $36.2 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered $36.2 million, $3.9 million, and $17.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.